Preschool Assessment of Preterm Infants Treated With Darbepoetin and Erythropoietin

BACKGROUND: We previously reported improved neurodevelopmental outcomes at 2 years among infants treated with the erythropoiesis-stimulating agents (ESAs) darbepoetin alfa (darbepoetin) or erythropoietin. Here we characterize 4-year outcomes. METHODS: Former preterm infants randomly assigned to rece...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Pediatrics
Main Authors: Ohls, Robin K., Cannon, Daniel C., Phillips, John, Caprihan, Arvind, Patel, Shrena, Winter, Sarah, Steffen, Michael, Yeo, Ronald A., Campbell, Richard, Wiedmeier, Susan, Baker, Shawna, Gonzales, Sean, Lowe, Jean
Formato: Artigo
Idioma:Inglês
Publicado: American Academy of Pediatrics 2016
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4771132/
https://ncbi.nlm.nih.gov/pubmed/26908704
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1542/peds.2015-3859
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares